A Randomized Phase 2 Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage IIIB/IV Non-Small Cell Lung Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Temozolomide (Primary)
- Indications Adenocarcinoma; Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 23 Mar 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.